US2020131555A1PendingUtilityA1

Incorporation of unnatural nucleotides and methods thereof

65
Assignee: SYNTHORX INCPriority: Jul 11, 2017Filed: Jul 10, 2018Published: Apr 30, 2020
Est. expiryJul 11, 2037(~11 yrs left)· nominal 20-yr term from priority
C12N 15/90C12N 15/113C12N 9/93C12P 21/02C12Y 601/01026C12N 15/11
65
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Disclosed herein are methods, compositions and kits for the synthesis of proteins which comprises unnatural amino acids that utilize a mutant tRNA.

Claims

exact text as granted — not AI-modified
1 .- 23 . (canceled) 
     
     
         24 . An  E. coli  cell comprising:
 (a) a nucleoside triphosphate transporter from  Phaeodactylum tricornutum;      (b) an mRNA comprising an unnatural base comprising a structure selected from   
       
         
           
           
               
               
           
         
         (c) a tRNA comprising an unnatural base comprising a structure selected from 
       
       
         
           
           
               
               
           
         
       
       and
 (d) an aminoacyl tRNA synthetase derived from an organism selected from the group consisting of  Methanosarcina barkeri  and  Methanococcus jannaschii.    
 
     
     
         25 . The  E. coli  cell of  claim 24 , wherein the cell further comprises an oligonucleotide encoding the mRNA. 
     
     
         26 . The  E. coli  cell of  claim 24 , wherein the cell further comprises an oligonucleotide encoding the tRNA. 
     
     
         27 . The  E. coli  cell of  claim 24 , wherein the cell further comprises an oligonucleotide encoding the aminoacyl tRNA synthetase. 
     
     
         28 . The  E. coli  cell of  claim 24 , wherein the cell further comprises a single oligonucleotide encoding the mRNA and the tRNA. 
     
     
         29 . The  E. coli  cell of  claim 24 , wherein the cell further comprises a single oligonucleotide encoding the mRNA, the tRNA, and the aminoacyl tRNA synthetase. 
     
     
         30 . The  E. coli  cell of  claim 24 , wherein the mRNA comprises one or more codons selected from AXC and GXC, wherein X is the unnatural base. 
     
     
         31 . The  E. coli  cell of  claim 30 , wherein the mRNA comprises the codon AXC. 
     
     
         32 . The  E. coli  cell of  claim 31 , wherein the unnatural base comprises the structure 
       
         
           
           
               
               
           
         
       
     
     
         33 . The  E. coli  cell of  claim 31 , wherein the unnatural base comprises the structure 
       
         
           
           
               
               
           
         
       
     
     
         34 . The  E. coli  cell of  claim 30 , wherein the mRNA comprises the codon GXC. 
     
     
         35 . The  E. coli  cell of  claim 34 , wherein the unnatural base comprises the structure 
       
         
           
           
               
               
           
         
       
     
     
         36 . The  E. coli  cell of  claim 34 , wherein the unnatural base comprises the structure 
       
         
           
           
               
               
           
         
       
     
     
         37 . The  E. coli  cell of  claim 24 , wherein the aminoacyl tRNA synthetase is derived from  Methanosarcina barkeri.    
     
     
         38 . The  E. coli  cell of  claim 36 , wherein the mRNA comprises an unnatural base comprising the structure 
       
         
           
           
               
               
           
         
       
       and the tRNA comprises an unnatural base comprising the structure 
       
         
           
           
               
               
           
         
       
     
     
         39 . The  E. coli  cell of  claim 37 , wherein the mRNA comprises one or more codons selected from AXC and GXC, wherein X is the unnatural base. 
     
     
         40 . The  E. coli  cell of  claim 24 , wherein the aminoacyl tRNA synthetase is derived from  Methanococcus jannaschii.    
     
     
         41 . The  E. coli  cell of  claim 39 , wherein the mRNA comprises an unnatural base comprising the structure 
       
         
           
           
               
               
           
         
       
       and the tRNA comprises an unnatural base comprising the structure 
       
         
           
           
               
               
           
         
       
     
     
         42 . The  E. coli  cell of  claim 40 , wherein the mRNA comprises one or more codons selected from AXC and GXC, wherein X is the unnatural base. 
     
     
         43 . The  E. coli  cell of  claim 24 , wherein the tRNA is derived from an organism selected from the group consisting of  Methanosarcina barkeri  and  Methanococcus jannaschii.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.